Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.

P, Gerami; RW, Cook; J, Wilkinson; MC, Russell; N, Dhillon; RN, Amaria; R, Gonzalez; S, Lyle; CE, Johnson; KM, Oelschlager; GL, Jackson; AJ, Greisinger; D, Maetzold; KA, Delman; DH, Lawson; JF, Stone

doi:10.1158/1078-0432.ccr-13-3316

Public

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.

Shared by NobleBlocks on Jan 1, 2015 • 12:00 AM UTC

Authors:

Gerami P

Cook RW

Wilkinson J

Abstract

Purpose The development of a genetic signature for the identification of high-risk cutaneous melanoma tumors would provide a valuable prognostic tool with value for stage I and II patients who represent a remarkably heterogeneous group with a 3% to 55% chance of disease progression and death 5 years...

Discussions